Smith Carrie Cox

Affiliations

  • Director at Organon & Co. (OGN), 2025-06-16
  • Director at Solventum Corp (SOLV), 2025-05-15
  • Director at Texas Instruments Inc (TXN), 2025-01-29
  • Director at Cartesian Therapeutics Inc. (RNAC), 2025-01-06
  • Director at Cardinal Health Inc (CAH), 2022-11-10
  • at Celgene Corp (CELG), 2019-11-22
  • Director at Array Biopharma Inc (ARRY), 2019-07-31
  • Director at Electrocore Inc. (ECOR), 2019-06-12
  • Officer at Merck & Co. Inc. (SGP), 2009-11-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OGN $8.07 12,469 $100,591.16 12,469 2025-05-14 Filing
SELB $1.15 130,000 $149,799.00 212,881 2022-06-13 Filing
SELB $2.95 17,200 $50,664.32 82,881 2021-12-03 Filing
ECOR $1.82 10,000 $18,200.00 21,000 2019-06-06 Filing
ARRY $23.20 5,000 $115,998.00 8,000 2019-02-19 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TXN $180.04 16,055 $2,890,542.20 35,801 2023-07-31 Filing
TXN $149.31 22,838 $3,409,978.32 34,065 2020-10-23 Filing
TXN $130.00 26,905 $3,497,650.00 34,065 2020-07-24 Filing
TXN $116.08 17,002 $1,973,571.76 33,299 2019-04-29 Filing
TXN $82.25 14,000 $1,151,500.00 31,435 2017-07-27 Filing